Pune, India -- (SBWIRE) -- 08/21/2018 -- The eye is the most tender body part of the human body. Disorders related to eyes might need expensive surgeries or therapies. That is why, despite being consumerist, people make efforts to follow a diet rich in Vitamin A and other important nutrients for perfect eyesight and good vision. Such a diet not only enhances the eye health, but sometimes is also helpful in the treatment of a number of eye-related ailments such as cataracts, diabetic retinopathy, and glaucoma. Dietary products for eye health are extracted from both synthetic sources as well as natural resources such as plants. Sometimes as tablets or tonics, these eye supplements are a strong market as long as perfect eyesight gets valued in this world.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4457

Market Research Future (MRFR) has published a research report that soothsays high-level advancement for the global eye care supplements market with 10.8% CAGR (Compound Annual Growth Rate) between 2017 and 2023. According to this report, the market for eye care supplements is expected to grow at an exponential rate because of chronic diseases like diabetes and various eye diseases becoming prevalent. Chronic diseases are risk factors for various eye-related ailments. The factors driving this market include increasing demand for eye care solutions around the world and various key players taking steps for geographical expansion. However, the cost of eye care supplements is likely to restrain the market growth in developing countries due to the purchasing power of consumer being lesser than the purchasing power of consumers in developed countries.

The global eye care supplements market has been segmented into application, end user, type, and lastly, region. On the basis of the application, this market has been segmented into the cataract, diabetic retinopathy, eye health, glaucoma, macular degeneration, and others. Diabetic retinopathy is a diabetes complication that affects the eyes. Glaucoma is an eye disease of in which fluid pressure within the eye rises. Macular Degeneration is caused by the deterioration of the central portion of the retina, which is the inside back layer of the eye. This layer records the images seen by the individual and sends them via the optic nerve from the eye to the brain.

Based on end users, the market has been segmented into eye clinics, eye hospitals, and others. By types, the market has been segmented into anti-inflammatory supplements, antioxidant, fatty acids, neuroprotective supplements and others. Anti-inflammatory supplements segment has been segmented into docosahexaenoic acid (DHA). DHA is an omega-3 fatty acid. It is a primary structural component of the cerebral cortex, human brain, retina, and skin. Antioxidants rich in lutein, Vitamin C, and zeaxanthin are beneficial to eyes. Neuro-protective has been segmented into eicosapentaenoic acid (EPA).

The regional segmentation of the global eye care supplements market has been segmented into regions namely The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). Due to technological advancement, more health consciousness among people, more investment on healthcare, support from governments on research and development (R & D), North America is a bigger market than South America and biggest market among all regional markets. In the United States of America (USA), the biggest market in North America, macular degeneration is the lead cause of people losing their vision. After the USA, Canada is another important market in this region.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4457

After North America, Europe is the second largest market for eye care supplements, which during the forecast period, is expected to experience steady growth due to the availability of cost-effective treatments and prevention strategy. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. Maximum revenue in Europe market comes from France, Germany, Italy, Spain, and the United Kingdom (UK).

In the Asia Pacific, the market is expected to grow at the fastest rate during the forecast period. Reasons for growth include increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy and obesity, high density of population and growing awareness among people about eye supplements. In this region, the biggest markets include Australia, China, India, Japan, and South Korea, followed by the rest of the Asia Pacific region. In MEA region, due to lack of political stability, healthcare not being considered a priority by governments, lack of awareness about eye ailments, and lack of scientific education and development, the market is small in this region. Maximum response to eye care supplements market in the MEA region comes from Kuwait, Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of the MEA region.

Key Players

The key players in the global eye care supplements market include Biosyntrx Inc. (USA), Bristol-Myers Squibb Company (USA), Bausch & Lomb Incorporated. (USA), Healths Harmony USA Supplements LLC (USA), Nordic Naturals Inc. (USA), NUSAPURE (USA), and Vitabiotics Ltd. (UK).

Latest Industry News

Bausch & Lomb, a key player in the global eye care supplements market, has introduced Ocuvite Blue Light eye vitamins. These vitamins are a nutritional supplement formulated with lutein and zeaxanthin. 12 JUNE 2018
PRN Therapeutics has announced the launch of Nuretin. Being helpful to diabetic retinopathy patients, this is a supplement formulated to manage high blood sugar levels that damage the retinal blood vessels. 2 APR 2018

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4457